United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD44 (Clone Hermes-1)
| Applications | Bl, ELISA, FC, IF, IHC, IP, Neutralize, WB |
| Reactivities | Human, Mouse, Rat, Goat, Primate, Rabbit, Sheep, Bovine |
Antibodies
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, FN, IP, WB |
| Reactivities | Human, Rabbit, Cow, Ferret |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Recombinant Anti-TLR2 (Clone TL2.1)
| Applications | Bl, FC, IF, IP, WB |
| Reactivities | Human |
Recombinant Anti-CD123 (Clone 7G3)
| Applications | Bl, FC, IP, WB |
| Reactivities | Human |
Anti-CD28 [9.3], Mouse IgG2a, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC |
| Reactivities | Human |
Recombinant Anti-Integrin beta-7 (Clone FIB27)
| Applications | Bl, FC, IP |
| Reactivities | Human, Mouse |
Recombinant Anti-Integrin beta-7 (Clone FIB504)
| Applications | Bl, FC, IF |
| Reactivities | Human, Mouse |
Recombinant Anti-CD18 (Clone 60.3)
| Applications | Bl, ELISA, WB |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-IL-9R (Clone AH9R2)
| Applications | Bl, IP |
| Reactivities | Human |
